Publications

2012

Original Article

• "Role of Pin2 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model"
  Y. Nakatsu, Y. Otani, H. Sakoda, J. Zhang, Y. Guo, H. Okubo, A. Kushiyama, M. Fujishiro, T. Kikuch, T. Fukushima, H. Ohno, Y. Tsuchiya, H. Kamata, A. Nagamachi, T. Inaba, F. Nishimura, H. Katagiri, S. Takahashi, H. Kurihara, T. Uchida and T. Asano
  J Biol Chem 287, 53, 44526-35 (2012).

  • URL
  • DOI: 10.1074/jbc.M112.397133

  23112047
• "Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications"
  H. Nakarai, A. Yamashita, S. Nagayasu, M. Iwashita, S. Kumamoto, H. Ohyama, M. Hata, Y. Soga, A. Kushiyama, T. Asano, Y. Abiko and F. Nishimura
  Innate Immun 18, 1, 164-70 (2012).

  • URL
  • DOI: 10.1177/1753425910393370

  21239459
• "Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development"
  A. Kushiyama, H. Okubo, H. Sakoda, T. Kikuchi, M. Fujishiro, H. Sato, S. Kushiyama, M. Iwashita, F. Nishimura, T. Fukushima, Y. Nakatsu, H. Kamata, S. Kawazu, Y. Higashi, H. Kurihara and T. Asano
  Arterioscler Thromb Vasc Biol 32, 2, 291-8 (2012).

  • URL
  • DOI: 10.1161/ATVBAHA.111.234559

  22095983
• "Angiotensin receptor 1 blocker valsartan normalizes gene expression profiles of 3T3-L1 adipocytes altered by co-culture with LPS-treated RAW264.8 macrophages"
  S. Kumamoto, A. Kushiyama, Y. Nakatsu, H. Sakoda, M. Fujishiro, M. Iwashita, H. Ohno, J. Zhang, Y. Guo, H. Aburatani, H. Kamata, F. Nishimura and T. Asano
  Obes Res Clin Pract 6, 4, e263-346 (2012).

  • URL
  • DOI: 10.1016/j.orcp.2012.05.005

  24331589
• "LST8 level controls basal p70 S6 kinase and Akt phosphorylations, and mTORC1 and mTORC2 negatively regulate each other by competing for association with LST9"
  T. Kikuchi, J. Zhang, H. Sakoda, Y. Koketsu, M. Fujishiro, A. Kushiyama, Y. Nakatsu, H. Kamata, K. Inoki, S. Takahashi, H. Kurihara, K. Hideki, Y. Oka and T. Asano
  Obes Res Clin Pract 6, 3, e175-262 (2012).

  • URL
  • DOI: 10.1016/j.orcp.2011.10.002

  24331524
• "Valsartan, independently of AT2 receptor or PPARgamma, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes"
  M. Iwashita, H. Sakoda, A. Kushiyama, M. Fujishiro, H. Ohno, Y. Nakatsu, T. Fukushima, S. Kumamoto, Y. Tsuchiya, T. Kikuchi, H. Kurihara, H. Akazawa, I. Komuro, H. Kamata, F. Nishimura and T. Asano
  Am J Physiol Endocrinol Metab 302, 3, E286-96 (2012).

  • URL
  • DOI: 10.1152/ajpendo.00324.2011

  22045314